<code id='CBDC379EB4'></code><style id='CBDC379EB4'></style>
    • <acronym id='CBDC379EB4'></acronym>
      <center id='CBDC379EB4'><center id='CBDC379EB4'><tfoot id='CBDC379EB4'></tfoot></center><abbr id='CBDC379EB4'><dir id='CBDC379EB4'><tfoot id='CBDC379EB4'></tfoot><noframes id='CBDC379EB4'>

    • <optgroup id='CBDC379EB4'><strike id='CBDC379EB4'><sup id='CBDC379EB4'></sup></strike><code id='CBDC379EB4'></code></optgroup>
        1. <b id='CBDC379EB4'><label id='CBDC379EB4'><select id='CBDC379EB4'><dt id='CBDC379EB4'><span id='CBDC379EB4'></span></dt></select></label></b><u id='CBDC379EB4'></u>
          <i id='CBDC379EB4'><strike id='CBDC379EB4'><tt id='CBDC379EB4'><pre id='CBDC379EB4'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:Wikipedia    Page View:565
          close-up of psoriasis on a hand. -- biotech coverage from STAT
          A close-up of psoriasis on a hand. Adobe

          San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

          Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

          advertisement

          Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'
          Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

          8:47PresidentJoeBidenspeaksabouttheSupremeCourt'sdecisiontostrikedownrace-consciousstudentadmissions

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          The strange history of BMI, the body mass index

          HyacinthEmpinado/STATThebodymassindex,orBMI,istheformulathat’susedmostoftentodiagnoseoverweightandob